Literature DB >> 8892623

Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand.

T Suda1, M Tanaka, K Miwa, S Nagata.   

Abstract

We have investigated the susceptibility of mouse T cells at various maturation and activation stages to recombinant soluble mouse Fas ligand (termed WX1). CD4+CD8+ thymocytes were preferentially killed by WX1, although CD4+CD8- and CD4-CD8+ thymocytes were also killed at higher concentrations of WX1. The majority of CD4-CD8- thymocytes were resistant to the same doses of WX1. Naive peripheral T cells were also killed by WX1 at concentrations similar to those for single-positive thymocytes. Activation-induced cell death of previously activated T cells is known to be mediated by Fas and Fas ligand. However, the activation of naive splenic T cells by mAbs against CD3/TCR complex rather induced resistance against WX1. This resistance was induced in activated T cells but not in bystander T cells. These mechanisms seem to explain why activated T cells are not immediately killed and why bystander T cells are not activated in an Ag-nonspecific manner.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892623

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Lack of activation induced cell death in human T blasts despite CD95L up-regulation: protection from apoptosis by MEK signalling.

Authors:  L S Walker; J D McLeod; G Boulougouris; Y I Patel; C N Ellwood; N D Hall; D M Sansom
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  Conditional Fas-associated death domain protein (FADD): GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis.

Authors:  Yuhang Zhang; Stephen Rosenberg; Hanming Wang; Hongxia Z Imtiyaz; Ying-Ju Hou; Jianke Zhang
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

3.  Activation of distinct caspase-like proteases by Fas and reaper in Drosophila cells.

Authors:  T Kondo; T Yokokura; S Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Elevated major histocompatibility complex class I expression protects T cells from antibody- and macrophage-mediated deletion.

Authors:  T Orlikowsky; Z Wang; A Dudhane; R Mittler; V Trejo; G E Dannecker; D Niethammer; M K Hoffmann
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

5.  A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes.

Authors:  K Newton; A W Harris; M L Bath; K G Smith; A Strasser
Journal:  EMBO J       Date:  1998-02-02       Impact factor: 11.598

6.  Differential ability of T cell subsets to undergo activation-induced cell death.

Authors:  A S Varadhachary; S N Perdow; C Hu; M Ramanarayanan; P Salgame
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

7.  Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes.

Authors:  A K Simon; O Williams; J Mongkolsapaya; B Jin; X N Xu; H Walczak; G R Screaton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

8.  Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex.

Authors:  Nils Holler; Aubry Tardivel; Magdalena Kovacsovics-Bankowski; Sylvie Hertig; Olivier Gaide; Fabio Martinon; Antoine Tinel; David Deperthes; Silvio Calderara; Therese Schulthess; Jürgen Engel; Pascal Schneider; Jürg Tschopp
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

9.  Increased spontaneous apoptosis in T lymphocytes in DiGeorge anomaly.

Authors:  S Gupta; S Aggarwal; T Nguyen
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

10.  CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling.

Authors:  Gudrun Strauss; Jonathan A Lindquist; Nathalie Arhel; Edward Felder; Sabine Karl; Tobias L Haas; Simone Fulda; Henning Walczak; Frank Kirchhoff; Klaus-Michael Debatin
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.